BioVie Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

30

BIVI
BioVie

Last Price:

3.06

Seasonality Move:

13.44%

Sell

30

NBY
NovaBay Pharmaceuticals

Last Price:

0.69

Seasonality Move:

-0.57%

Sell

30

BioVie (BIVI) is a Sell

Is BioVie a Buy, Sell or Hold?

The current BioVie [BIVI] share price is $3.11. The Score for BIVI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
BIVI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

30

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIVI Stock Price Chart

What is BioVie's stock price today?

The BioVie share price today is $3.11
The current trend is moderately bullish and BIVI is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIVI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.3	Buy
Relative Strength Index (14 RSI):	56.34	Buy
Chaikin Money Flow:	-1520057	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.56 - 3.26)	Buy
Bollinger Bands (100):	(1.88 - 3.86)	Buy

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.02	Buy
Relative Strength Index (14 RSI):	54.51	Buy
Chaikin Money Flow:	23717	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.61 - 0.75)	Buy
Bollinger Bands (100):	(0.27 - 1.45)	Sell

BIVI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.32	Sell
20-day SMA:	2.95	Buy
50-day SMA:	2.33	Buy
200-day SMA:	4.64	Sell
8-day EMA:	3.22	Sell
20-day EMA:	2.94	Buy
50-day EMA:	2.7	Buy
200-day EMA:	7.66	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.72	Sell
20-day SMA:	0.7	Buy
50-day SMA:	0.66	Buy
200-day SMA:	2.35	Sell
8-day EMA:	0.71	Buy
20-day EMA:	0.7	Buy
50-day EMA:	0.73	Sell
200-day EMA:	5.62	Sell

BioVie Earnings Growth & BIVI Earnings Dates

Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

BioVie Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):